InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,682.40
(
0.00%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.64
(
0.31%
)
Bitcoin
61,654.72
(
0.34%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bellweather1

Send PM Follow Ignore
Followers 11
Posts 2370
Boards Moderated 0
Alias Born 06/08/2010

bellweather1

Re: None

Tuesday, 10/18/2011 11:32:41 AM

Tuesday, October 18, 2011 11:32:41 AM

Post# of 80490
ARIA/HGSI-

Could be us in the not too distant future(although I think they needed this a lot more than us):

Monday 6:13 PM GlaxoSmithKline (GSK) may bid $25/share for Human Genome Sciences (HGSI), the Daily Mail speculates, citing their partnership in developing the FDA-approved lupus drug Benlysta. With Merck (MRK) and Biogen (BIIB) also sniffing around the company, GSK "could decide now would be an opportune time to make a move on HGS." HGSI +4.9% AH.
Seeking Alpha(Market Currents)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up